INS and Hyperglycemia: In STZ induced hyperglycemic mice model, PGLP-1-VP ameliorates STZ-induced hyperglycemia and improves insulin sensitivity, which indicates that PGLP-1-VP could work as a long-acting GLP-1R agonist in vivo.